Offering state-of-the-art analytical, formulation and drug product processing equipment.
Ready to help customers meet some of the greatest challenges in patient treatment.
Based at the Stücki Technology Park, Basel.
Our drug product services (DPS) team has deep expertise in the development, manufacture and analysis of parenteral formulations and finished drug products for injection, infusion or implant of a variety of product types and molecules. The drug product analytical development and quality control (QC) group has industry-leading technical, scientific and regulatory expertise in method development, product characterization and testing of biopharmaceuticals.
Specialized services are available for particulate identification, characterization and quantification, excipient and surfactant characterization, extractables and leachables assessment, product comparability and testing of container closure integrity and drug/device combination products.
Basel operates under the global quality management system which complies with internal policies as well as with national and international regulations. Since receiving the GMP certificate in 2017, our drug product services have had multiple successful inspections from health authorities, in addition to successful customer and self-inspections.
Our DPS team has developed proprietary, IP-protected container-closure integrity (CCI) testing.
That proprietary system can evaluate CCI using highest sensitive helium leakage pCCI testing for vials, syringes and cartridges and can evaluate specific requirements, such as the impact of stopper height on CCI, as per recent Annex 1 GMP requirements.
Sustainability